HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing

The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle to successful antiretroviral therapy (ART) in the low- and middle-income countries (LMICs) hardest hit by the HIV-1 pandemic. Genotypic drug resistance testing could facilitate the choice of initial ART in are...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Rhee, Soo-Yon, Jordan, Michael R., Raizes, Elliot, Chua, Arlene, Parkin, Neil, Kantor, Rami, Van Zyl, Gert U., Mukui, Irene, Hosseinipour, Mina C., Frenkel, Lisa M., Ndembi, Nicaise, Hamers, Raph L., Rinke de Wit, Tobias F., Wallis, Carole L., Gupta, Ravindra K., Fokam, Joseph, Zeh, Clement, Schapiro, Jonathan M., Carmona, Sergio, Katzenstein, David, Tang, Michele, Aghokeng, Avelin F., De Oliveira, Tulio, Wensing, Annemarie M. J., Gallant, Joel E., Wainberg, Mark A., Richman, Douglas D., Fitzgibbon, Joseph E., Schito, Marco, Bertagnolio, Silvia, Yang, Chunfu, Shafer, Robert W.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696791/
https://ncbi.nlm.nih.gov/pubmed/26717411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0145772
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados